Used Zimmer Biomet NexGen for Sale in Maryland
Baltimore-area joint replacement centers run Zimmer Biomet NexGen for rotating-platform total knee replacement near the DC metro's premium joint replacement market. Maryland pricing runs about 10% above baseline.
Maryland units run 10% above baseline: $2,200–$6,050.
Zimmer Biomet NexGen - Key specifications
- Total knee
- rotating platform
Pricing in Maryland
Zimmer Biomet NexGen vs alternatives
| Model | Brand | Used Price | Key Spec |
|---|---|---|---|
| Zimmer Biomet NexGen ✓ | Zimmer Biomet | $2,000–$5,500 | Total knee, rotating platform... |
| OEC 9900 Elite | GE Healthcare | $30,000–$70,000 | C-arm fluoroscopy, 9-inch II, mobile... |
| Cios Select | Siemens | $25,000–$55,000 | C-arm, flat panel, carbon fiber table... |
| Vision R Iso-C | Ziehm | $22,000–$50,000 | Mobile C-arm, isocentric, 3D... |
Active buyers in Maryland
Facilities in Maryland currently using or sourcing Zimmer Biomet NexGen:
- Johns Hopkins Hospital, Baltimore
- University of Maryland Medical Center, Baltimore
- MedStar Washington Hospital Center, Washington D.C. metro
- Sinai Hospital of Baltimore, Baltimore
- Greater Baltimore Medical Center, Towson
Clinical experts on Zimmer Biomet NexGen
- Dr. Kevin Wilk - ASMI Birmingham. isokinetic testing and rehabilitation equipment specialist.
FAQ - Zimmer Biomet NexGen in Maryland
Why does Maryland pricing run above baseline for Zimmer Biomet NexGen?
Proximity to the Washington DC metro area's higher cost of living and concentration of joint replacement centers supports pricing above the national baseline.
What is the price of used Zimmer Biomet NexGen in Maryland?
Maryland units run 10% above baseline: $2,200–$6,050. Price depends on hours, condition grade, and included accessories.
Does TechCosmetic ship Zimmer Biomet NexGen to Maryland?
Yes. We ship to all 50 states including Maryland. Freight quotes within 24 hours, coordinated with local riggers in major Maryland cities.
More on Zimmer Biomet NexGen
Similar equipment
Zero buyer commission · 2-hour response